Codes / ICD10CM / M1A.2120

M1A.2120 Drug-induced chronic gout, left shoulder, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Left Shoulder, Without Tophus (Tophi)

Summary

Drug-induced chronic gout, left shoulder, without tophus is a form of arthritis affecting the left shoulder joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the presence of tophi (urate crystal deposits).

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left shoulder joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense left shoulder pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected shoulder
  • Stiffness and limited range of motion in the left shoulder
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging to assess joint inflammation and rule out other conditions. Synovial fluid analysis may confirm urate crystal presence, while imaging helps evaluate joint damage. Documentation must specify the left shoulder and absence of tophi.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include discontinuing or adjusting the causative medication, using urate-lowering therapies (e.g., allopurinol), and anti-inflammatory agents for acute flares. Physical therapy may help maintain joint function.

Prognosis and Follow-Up

With appropriate management, symptoms can be controlled, but chronic joint damage may occur if uric acid levels remain elevated. Regular follow-up is essential to monitor uric acid levels, adjust medications, and assess joint function. Long-term adherence to treatment improves outcomes.

Complications

Untreated or poorly managed cases may lead to persistent joint damage, reduced mobility, or progression to chronic arthritis. Rarely, severe inflammation could cause joint deformity or functional impairment.

Lifestyle & Prevention

Avoiding medications that raise uric acid levels (when possible) and maintaining a balanced diet low in purines can help. Staying hydrated and managing weight may also reduce risk. Consult a healthcare provider before adjusting medications.

When to Seek Professional Help

Seek care if experiencing severe or worsening shoulder pain, swelling, or stiffness, or if symptoms interfere with daily activities. Prompt evaluation is important to prevent joint damage and adjust treatment as needed.

Tips for Medical Coders

Use this code for drug-induced chronic gout affecting the left shoulder without tophi. Ensure documentation specifies the left shoulder and absence of tophi. Verify that the condition is chronic and drug-induced, with no tophaceous deposits present.

Book a walkthrough

M1A.2120 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.